» Articles » PMID: 37511580

Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 29
PMID 37511580
Authors
Affiliations
Soon will be listed here.
Abstract

Kinase Suppressor of RAS 1 (KSR1) is a scaffolding protein for the RAS-RAF-MEK-ERK pathway, which is one of the most frequently altered pathways in human cancers. Previous results have shown that KSR1 has a critical role in mutant RAS-mediated transformation. Here, we examined the role of KSR1 in mutant BRAF transformation. We used CRISPR/Cas9 to knock out KSR1 in a BRAFV600E-transformed melanoma cell line. KSR1 loss produced a complex phenotype characterised by impaired proliferation, cell cycle defects, decreased transformation, decreased invasive migration, increased cellular senescence, and increased apoptosis. To decipher this phenotype, we used a combination of proteomic ERK substrate profiling, global protein expression profiling, and biochemical validation assays. The results suggest that KSR1 directs ERK to phosphorylate substrates that have a critical role in ensuring cell survival. The results further indicate that KSR1 loss induces the activation of p38 Mitogen-Activated Protein Kinase (MAPK) and subsequent cell cycle aberrations and senescence. In summary, KSR1 function plays a key role in oncogenic BRAF transformation.

Citing Articles

ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.

Liu B, Chen M, Liang Y, Mei Z, Sun W, Gao W Hum Cell. 2024; 38(1):23.

PMID: 39614918 DOI: 10.1007/s13577-024-01155-x.


Imaging the Raf-MEK-ERK Signaling Cascade in Living Cells.

Shin Y, Cho M, Hwang J, Myung K, Kweon H, Lee Z Int J Mol Sci. 2024; 25(19).

PMID: 39408915 PMC: 11477372. DOI: 10.3390/ijms251910587.


Enzyme Is the Name-Adapter Is the Game.

Huber M, Brummer T Cells. 2024; 13(15.

PMID: 39120280 PMC: 11311582. DOI: 10.3390/cells13151249.

References
1.
Casar B, Arozarena I, Sanz-Moreno V, Pinto A, Agudo-Ibanez L, Marais R . Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins. Mol Cell Biol. 2008; 29(5):1338-53. PMC: 2643815. DOI: 10.1128/MCB.01359-08. View

2.
Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, Nebreda A . p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol. 2009; 29(16):4341-51. PMC: 2725730. DOI: 10.1128/MCB.00210-09. View

3.
Lozano J, Xing R, Cai Z, Jensen H, Trempus C, Mark W . Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res. 2003; 63(14):4232-8. View

4.
Yan F, John S, Wilson G, Jones D, Washington M, Polk D . Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J Clin Invest. 2004; 114(9):1272-80. PMC: 524224. DOI: 10.1172/JCI21022. View

5.
Wang S, Bellen H . The retromer complex in development and disease. Development. 2015; 142(14):2392-6. PMC: 4510866. DOI: 10.1242/dev.123737. View